| (INR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 22.29B | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, JUBLPHARMA.NS returned -18.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -17.6% |
| 1 year | -18.3% |
| 5 years | +41.9% |
| 10 years | +144.0% |
| All-time high | ₹1,234.25 (Nov 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₹1,000 in JUBLPHARMA.NS would be worth today ›Yes. Jubilant Pharmova Limited paid 1 dividend over the past 12 months. The most recent was ₹5.00 per share on Jul 24, 2026. The dividend yield is 0.57%.
Jubilant Pharmova Limited is part of the Healthcare sector.
Jubilant Pharmova Limited has a market cap of 142.98B INR, based on the latest quote.
Jubilant Pharmova Limited is expected to report earnings around Oct 30, 2026. That date is an estimate and has not been confirmed by the company.
